Inherited missense mutations in the tumor suppressor gene, BRCA-1, may predispose to breast or ovarian cancer, but the exact effects on the protein are generally unknown. The COOH-terminal region of BRCA-1 encodes two BRCT repeats, which are partially con-served in mammalian species (human, dog, rat, and mouse; 60 % amino acid identity). A bioinformatic analysis was conducted to evaluate 246 BRCT missense mutations from high-risk breast and/or ovarian cancer patients (reported in the NIH Breast Cancer Informa-tion Core database). It was hypothesized that amino acids conserved in evolution would be disproportion-ately targeted by the mutations and that conserved amino acids with strongly hydrophobic side chains would be disproportionately pe...
Previous studies have reported variation in BRCA1 breast and ovarian cancer risks with mutation posi...
Mutations in BRCA1 and BRCA2 are responsible for a large proportion of breast-ovarian cancer familie...
Background—Missense (amino-acid changing) variants found in cancer predisposition genes often create...
Thesis (Ph. D.)--University of Washington, 2005.Half of coding single-nucleotide polymorphisms in th...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
to date result in the premature translational termina-tion of the protein, highlighting a crucial ro...
PurposeGermline genetic testing for BRCA1 and BRCA2 variants has been a part of clinical practice fo...
Previous studies have reported variation in BRCA1 breast and ovarian cancer risks with mutation posi...
Five to ten percent of breast cancer in the western world may be attributed to the inheritance of hi...
BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of bo...
WOS:000454834200006International audienceBRCA1 mutations have been identified that increase the risk...
BRCA1 (breast cancer 1, early onset) mutations confer a high risk of breast and ovarian cancer. Most...
Pathogenic mutations in BRCA1 are associated with an increased risk of hereditary breast, ovarian, a...
The BRCA1 gene from individuals at risk of breast and ovarian cancers can be screened for the presen...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
Previous studies have reported variation in BRCA1 breast and ovarian cancer risks with mutation posi...
Mutations in BRCA1 and BRCA2 are responsible for a large proportion of breast-ovarian cancer familie...
Background—Missense (amino-acid changing) variants found in cancer predisposition genes often create...
Thesis (Ph. D.)--University of Washington, 2005.Half of coding single-nucleotide polymorphisms in th...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
to date result in the premature translational termina-tion of the protein, highlighting a crucial ro...
PurposeGermline genetic testing for BRCA1 and BRCA2 variants has been a part of clinical practice fo...
Previous studies have reported variation in BRCA1 breast and ovarian cancer risks with mutation posi...
Five to ten percent of breast cancer in the western world may be attributed to the inheritance of hi...
BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of bo...
WOS:000454834200006International audienceBRCA1 mutations have been identified that increase the risk...
BRCA1 (breast cancer 1, early onset) mutations confer a high risk of breast and ovarian cancer. Most...
Pathogenic mutations in BRCA1 are associated with an increased risk of hereditary breast, ovarian, a...
The BRCA1 gene from individuals at risk of breast and ovarian cancers can be screened for the presen...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
Previous studies have reported variation in BRCA1 breast and ovarian cancer risks with mutation posi...
Mutations in BRCA1 and BRCA2 are responsible for a large proportion of breast-ovarian cancer familie...
Background—Missense (amino-acid changing) variants found in cancer predisposition genes often create...